422 related articles for article (PubMed ID: 17879327)
21. Strength of evidence of non-inferiority trials-The adjustment of the type I error rate in non-inferiority trials with the synthesis method.
Kang SH; Tsong Y
Stat Med; 2010 Jun; 29(14):1477-87. PubMed ID: 20535762
[TBL] [Abstract][Full Text] [Related]
22. Multiple-arm superiority and non-inferiority designs with various endpoints.
Chang M
Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
[TBL] [Abstract][Full Text] [Related]
23. A mixed approach for proving non-inferiority in clinical trials with binary endpoints.
Rousson V; Seifert B
Biom J; 2008 Apr; 50(2):190-204. PubMed ID: 18311852
[TBL] [Abstract][Full Text] [Related]
24. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
Matilde Sanchez M; Chen X
Stat Med; 2006 Apr; 25(7):1169-81. PubMed ID: 16397861
[TBL] [Abstract][Full Text] [Related]
25. A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority.
Shao Y; Mukhi V; Goldberg JD
Stat Med; 2008 Feb; 27(4):504-19. PubMed ID: 17854052
[TBL] [Abstract][Full Text] [Related]
26. An alternative to the use of two-sided tests in clinical trials.
Dunnett CW; Gent M
Stat Med; 1996 Aug; 15(16):1729-38. PubMed ID: 8870155
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
Tsong Y; Zhang J
J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
[TBL] [Abstract][Full Text] [Related]
28. Blinded sample size reassessment in non-inferiority and equivalence trials.
Friede T; Kieser M
Stat Med; 2003 Mar; 22(6):995-1007. PubMed ID: 12627414
[TBL] [Abstract][Full Text] [Related]
29. [Statistical notes. From superiority to non-inferiority clinical trials: a leap in the dark?].
Marubini E; Rebora P; Reina G
Ital Heart J Suppl; 2004 Sep; 5(9):712-9. PubMed ID: 15568609
[TBL] [Abstract][Full Text] [Related]
30. Mixed noninferiority margin and statistical tests in active controlled trials.
Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
[TBL] [Abstract][Full Text] [Related]
31. Comparative evaluation of ectoparasiticide efficacy: non-inferiority and superiority assessment.
Schall R; Luus HG
Vet Parasitol; 2011 May; 178(1-2):173-9. PubMed ID: 21242034
[TBL] [Abstract][Full Text] [Related]
32. A useful testing strategy in phase III trials: combined test of superiority and test of equivalence.
Morikawa T; Yoshida M
J Biopharm Stat; 1995 Nov; 5(3):297-306. PubMed ID: 8580930
[TBL] [Abstract][Full Text] [Related]
33. A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority.
Koyama T; Sampson AR; Gleser LJ
Stat Med; 2005 Aug; 24(16):2439-56. PubMed ID: 15977285
[TBL] [Abstract][Full Text] [Related]
34. Noninferiority testing beyond simple two-sample comparison.
Tsong Y; Chen WJ
J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
[TBL] [Abstract][Full Text] [Related]
35. Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves.
Liu JP; Ma MC; Wu CY; Tai JY
Stat Med; 2006 Apr; 25(7):1219-38. PubMed ID: 16158400
[TBL] [Abstract][Full Text] [Related]
36. Testing superiority at interim analyses in a non-inferiority trial.
Chen YH; Chen C
Stat Med; 2012 Jul; 31(15):1531-42. PubMed ID: 22438208
[TBL] [Abstract][Full Text] [Related]
37. Challenges and regulatory experiences with non-inferiority trial design without placebo arm.
Hung HM; Wang SJ; O'Neill R
Biom J; 2009 Apr; 51(2):324-34. PubMed ID: 19358213
[TBL] [Abstract][Full Text] [Related]
38. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
Lui KJ; Chang KC
Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
[TBL] [Abstract][Full Text] [Related]
39. On non-inferiority analysis based on delta-method confidence intervals.
Rothmann MD; Tsou HH
J Biopharm Stat; 2003 Aug; 13(3):565-83. PubMed ID: 12921402
[TBL] [Abstract][Full Text] [Related]
40. Non-inferiority trials: the 'at least as good as' criterion with dichotomous data.
Laster LL; Johnson MF; Kotler ML
Stat Med; 2006 Apr; 25(7):1115-30. PubMed ID: 16381070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
